According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031.
Graft versus Host Disease, a serious complication following stem cell or bone...
Global Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share
CAGR Value
Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...
According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031.
Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek